Designed for Those Focused on Health and Wellness, the New Line Uses Entire Power of the Hemp Plant for an Enhanced Experience and is Now Available Online and in Select Columbia Care Dispensaries
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis and hemp derived CBD products in the United States, and international superstar Pitbull, today announced the launch of N2P – a new line of high quality, full spectrum CBD products for those seeking to incorporate CBD into their health and wellness routines. N2P seeks to change the negative perception of CBD products and to shine a positive light on the potential of these products, which is what N2P stands for: negative to positive.
“We are committed to changing the conversation around CBD and providing a line of products that people can trust and expect that they’ll receive the best experience possible,” said Jesse Channon, Chief Growth Officer of Columbia Care. “We’ve partnered with Pitbull because of his passion for CBD and high-quality excellence. Together, we’re working to introduce premium, full spectrum CBD products for customers who are enthusiastic about health and wellness, but also for those who are curious about CBD and have been hesitant to try it – we want everyone to be able to change a negative to a positive.”
The N2P product line is formulated with quality in mind. Derived from natural, U.S.-grown hemp, these products are specially designed to tap into the plant’s full potential to help support everyday wellness, such as promoting recovery from exercise, soothing comfort from day-to-day stresses, and supporting natural sleep cycles. The initial product offerings will feature lip balms, salves, tinctures and sour gummies. Chocolate products will be released later in 2021.
“I’m honored to partner with Columbia Care to announce our new CBD line N2P (Negative to Positive),” said Armando Christian Perez (Pitbull). “N2P is an all-natural, high-quality product directed at the therapeutic benefits of CBD. It’s designed to help customers stay focused, positive and feeling their best. It’s our goal to change the perception about the health and wellness benefits of CBD products. We look forward to sharing N2P with fans around the world, Dale!”
At launch, the N2P line includes:
3-pack of Pina Colada Lip Balms (150mg CBD, 50mg per balm)
2oz Relief Salve (250mg CBD)
1oz Star Fruit Tincture (1,000mg CBD, 33.3mg CBD per serving)
30ct. Gummies (750mg CBD, 25mg per gummy)
N2P products will be available in select states for purchase online at www.n2pwellness.com and in select Columbia Care dispensaries in Delaware, Maryland and New York. They will also be available at The Green Solution dispensaries in Colorado later this year.
About Columbia Care
Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 18 U.S. jurisdictions and the EU. Columbia Care operates 130 facilities including 99 dispensaries and 31 cultivation and manufacturing facilities, including those under development. Columbia Care is one of the original providers of medical cannabis in the U.S. and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber and Platinum Label CBD. For more information on Columbia Care, please visit www.col-care.com.
Caution Concerning Forward-Looking Statements
This press release contains certain statements that constitute forward-looking information within the meaning of applicable securities laws and reflect the Company’s current expectations regarding future events. The Company has made assumptions with regard to its ability to execute on brand and product initiatives, which although considered reasonable by the Company, may prove to be incorrect and are subject to known and unknown risks and uncertainties that may cause actual results, performance or achievements of the Company to be materially different from those expressed or implied by any forward-looking information. Securityholders should review the risk factors discussed under “Risk Factors” in Columbia Care’s Annual Information Form dated March 31, 2021, filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com and described from time to time in documents filed by the Company with Canadian securities regulatory authorities.